Classification of intestinal inflammation driven by gut microbiota metabolites: a new paradigm for precision treatment of cardiovascular diseases. [PDF]
Front MicrobiolZhao D, Cui Y, Hua Z.
europepmc +1 more source
The role of gut dysbiosis in endocrine and metabolic derangements of chronic kidney disease: mechanisms, controversies, and future perspectives. [PDF]
Front Endocrinol (Lausanne)Ouyang Z +5 more
europepmc +1 more source
Trimethylamine-N-oxide: the microbial cue in immune-mediated disorders. [PDF]
Trends Endocrinol MetabMirji G, Bhat SA, Shinde RS.
europepmc +1 more source
Impact of infrared moxibustion for patients with mild hyperlipidemia: a protocol for a randomized controlled trial. [PDF]
Ann MedXie H +9 more
europepmc +1 more source
Targeting the Gut-Heart Axis in Diabetic Heart Failure: Microbiota and SGLT2is as Converging Therapeutic Frontiers. [PDF]
Int J Mol SciChu Y, Huang KH, Tseng CN.
europepmc +1 more source
Gut Microbiota Dysbiosis and Risk of Venous Thromboembolism: A Systematic Review. [PDF]
MicroorganismsFranco-Moreno A +7 more
europepmc +1 more source
Depressive symptoms in chronic kidney disease: the hidden role of uremic toxins. [PDF]
BMJ Ment HealthLevassort H +18 more
europepmc +1 more source
Gut dysbiosis contributes to TMAO accumulation in CKD
Nephrology Dialysis TransplantationJohannes Holle +10 more
openaire +2 more sources
Gut microbial-derived metabolites: key players in kidney disease and renal fibrosis. [PDF]
Int J Biol SciZhang WY +6 more
europepmc +1 more source